Management of challenging cases of patients with cancer‐associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH
- 27 June 2013
- journal article
- practice guideline
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 11 (9), 1760-1765
- https://doi.org/10.1111/jth.12338
Abstract
No abstract availableFunding Information
- Sondra and Stephen Hardis Endowed Chair in Oncology
This publication has 38 references indexed in Scilit:
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2013
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerJournal of Thrombosis and Haemostasis, 2012
- Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous ThromboembolismCirculation, 2012
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2012
- Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2011
- Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patientsJournal of Thrombosis and Haemostasis, 2009
- Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with CancerAmerican Journal Of Medicine, 2006
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerThe New England Journal of Medicine, 2003
- Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With CancerArchives of Internal Medicine, 2002